![(S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride Structure](https://www.chemicalbook.com/CAS/20200401/GIF/2254176-11-7.gif)
(S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- Product Name(S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- CAS2254176-11-7
- CBNumberCB75559683
- MFC17H19ClFN3O4
- MW383.8
- EINECS-0
- MOL File2254176-11-7.mol
(S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride Chemical Properties,Usage,Production
Uses
Desmethyl Levofloxacin hydrochloride is an antibacterial agent with broad-spectrum antibacterial activity against a variety of pathogens. Desmethyl Levofloxacin hydrochloride effectively fights bacterial infections by inhibiting bacterial DNA synthesis. Studies on Desmethyl Levofloxacin hydrochloride have shown that it has potential in inhibiting respiratory infections[1].References
[1] Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86. DOI:10.2147/COPD.S55419[2] Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial DOI:10.2147/COPD.S55419
(S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride Suppliers
Global(32)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +91-172-5066494 | mktg@pharmaffiliates.com | Haryana，India | 6665 | 58 | |
| +86-17320513646 +86-17320513646 | anna@molcoo.com | 9997 | 58 | ||
| +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | 32430 | 58 | ||
| 16314854226; +8616314854226 | inquiry@bocsci.com | 19852 | 58 | ||
| +86-571-87711850 +8619957148339 | market18@leapchem.com | 24569 | 58 | ||
| +1-781-999-5354; | support@targetmol.com | 38999 | 58 | ||
| 027-87531629 | Proteintech-CN@ptglab.com | 6276 | 58 | ||
| 021-38015121-8802 | chenjw@absin.cn | 6913 | 58 | ||
| 18126517264 | 2850476883@qq.com | 7879 | 58 | ||
| 020-81960175-877 18933936954 | tianwen.zhan@cato-chem.com | 7334 | 58 |
2254176-11-7((S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride) Related Search
- Levofloxacin Methylate
- Levofloxacin hydrochloride
- Levofloxacin heMihydrate
- Levofloxacin
- Levofloxacin Impurity 9
- (R)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- (S)-methyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino [2,3,4-ij]quinoline-6-carboxylate
- Levofloxacin DiaMine
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI)
- Levofloxacin Impurity 15
1of4